If a doctor, nurse, dentist or optician thinks your symptoms could be cancer, they send an urgent referral so tests happen quickly. Most people referred do not have cancer. In England the aim is that you are told whether you have cancer within 28 days; Scotland and Wales count 62 days to the start of treatment. If you are not referred, you should be told what to watch for and when to come back.
Threshold. The Scottish Referral Guidelines 2025 rest on a positive predictive value of 3% or more, which they describe as in line with NICE; Scotland reviewed lowering it and kept it. NICE NG12 (last updated April 2026) defines urgent as before 2 weeks, very urgent as within 48 hours and immediate as within a few hours, and since October 2023 defines a suspected cancer pathway referral by a 28-day outcome (diagnosis or ruling out of cancer); Cancer Research UK states that England's two-week target was replaced by the Faster Diagnosis Standard from October 2023.
Referral (NG12 1.14 to 1.16). Tell the person they are being referred to a cancer service and that most people referred do not have cancer; say where, how long, which tests, and who to contact if no appointment arrives; make the referral within 1 working day, on the local form where one is in use; consider discussing with a specialist when unsure; have local arrangements to follow up people who miss appointments. In Scotland and Wales the receiving specialty may regrade a referral after triage, with the referrer and the patient told.
Safety netting (NG12 1.15). Whoever orders a test acts on the result or explicitly hands that on; for people with a symptom linked to cancer who do not meet criteria, NICE says to consider a planned or patient-initiated review, and to explain what to look for and when to return.
Time standards. England: NG12 gives the 28-day definition and points to NHS England for the detail. The Handbook to the NHS Constitution for England (updated January 2025) states a maximum 28-day wait from receipt of an urgent referral to being told of a diagnosis or that cancer is ruled out, a 31-day wait from decision to treat to treatment, and a 62-day wait from receipt of an urgent referral to first definitive treatment. NHS England's own guidance, which holds the percentage each must be met for and the detailed clock rules, could not be read, so no percentage for England is given here. Scotland: 62 days from urgent suspicion of cancer referral to first treatment and 31 days from decision to treat, each 95%; in April to June 2026, 73.6% and 94.8%. Wales: one suspected cancer pathway, 62 days from the point of suspicion (for a GP referral, the day it is sent) to first definitive treatment, at least 75%. Neither the Scottish nor the Welsh document read sets a standard for the day the diagnosis is communicated, and Cancer Research UK states that Scotland, Wales and Northern Ireland have no faster diagnosis standard; the Welsh circular requires that decisions are communicated within 24 hours for a diagnosis. Northern Ireland: Cancer Research UK gives 62-day and 31-day targets; Northern Ireland's own documents were not read.
This page describes how the route is meant to work. The referral criteria and timings your own GP practice and hospital follow come first.
Why: The Scottish guidelines set their criteria at this level and describe it as in line with NICE, while noting that the figures were not available for every cancer type. A threshold this low means people are sent for tests while the chance of cancer is still small.
“This meant that a person should be referred for urgent assessment if there was a 3% (or greater) chance of their clinical features being due to cancer.”
Scottish Government and the Centre for Sustainable Delivery 2025
Why: NICE keeps a separate, faster category for a small number of presentations, for example a child or young person with unexplained petechiae or an enlarged liver and spleen, who is referred immediately for possible leukaemia.
“An acute admission or referral occurring within a few hours, or even more quickly if necessary.”
Why: NICE adds that this may also let the GP pass on their concern and a sense of urgency when the symptoms are not typical.
“Discussion with a specialist (for example, by telephone or email) should be considered if there is uncertainty about the interpretation of symptoms and signs, and whether a referral is needed.”
NICE 2026 · [2005]
Why: NICE describes these pathways as designed for people whose symptoms do not clearly fit a referral pathway for one cancer. In Scotland the equivalent depends on the health board.
“This pathway should apply when symptoms are suggestive of cancer but do not clearly meet tumour-specific suspected cancer pathway referral criteria.”
Why: The person should know why they are being referred, and NICE asks that they are reassured, as appropriate, that most people referred will not have cancer and that other diagnoses are discussed with them.
“Explain to people who are being referred with suspected cancer that they are being referred to a cancer service. Reassure them, as appropriate, that most people referred will not have a diagnosis of cancer, and discuss alternative diagnoses with them.”
NICE 2026 · [2015]
Why: NICE lists these among the things people with suspected cancer, and their families and carers, should be told. Someone who knows when they should have heard, and who to contact, can chase an appointment that has not arrived.
“who to contact if they do not receive confirmation of an appointment”
NICE 2026 · [2015]
Why: NICE sets this limit so that the referral itself adds no more than a working day to the wait.
“Once the decision to refer has been made, make sure that the referral is made within 1 working day.”
NICE 2026 · [2005]
Why: NICE asks that support continues while the person waits for the appointment, and that they can come back with concerns or questions before they see a specialist.
“When referring a person with suspected cancer to a specialist service, assess their need for continuing support while waiting for their referral appointment.”
NICE 2026 · [2005]
Why: A person who misses an appointment still has the symptom that led to the referral, so NICE asks for local arrangements to identify and follow them up.
“Ensure local arrangements are in place to identify people who miss their appointments so that they can be followed up.”
NICE 2026 · [2005]
Why: This is the Scottish rule; the Welsh circular also says the decision and reasons should go to the referrer and the patient. The Scottish guidelines note that vital information may have been left off the referral, and that the referrer should be able to explain why it was sent as urgent.
“The referring GP practice should be notified promptly of any regrading with clear communication about decisions to reduce patient anxiety and facilitate continuity of care.”
Scottish Government and the Centre for Sustainable Delivery 2025
Why: England's standard counts being told that cancer is ruled out as well as being told of a diagnosis. Cancer Research UK states that Scotland, Wales and Northern Ireland have no such standard.
“Person to receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their GP for suspected cancer.”
Why: The Scottish guidelines say the urgent pathway is there to find the cause of the symptoms, so the symptom that started the referral still needs an explanation.
“For people whose presenting symptoms persist, it is not acceptable to simply exclude cancer without providing an assessment of the underlying cause.”
Scottish Government and the Centre for Sustainable Delivery 2025
Why: NICE makes this the first part of safety netting, so that no result is left without someone responsible for it. It also asks clinicians to be aware that chest X-rays and tests for hidden blood in faeces can give false-negative results.
“Ensure that the results of investigations are reviewed and acted upon appropriately, with the healthcare professional who ordered the investigation taking or explicitly passing on responsibility for this.”
NICE 2026 · [2015]
Why: NICE describes this as monitoring people at low risk, but not no risk, of cancer to see whether their risk changes.
“Consider a review for people with any symptom that is associated with an increased risk of cancer, but who do not meet the criteria for referral or other investigative action.”
NICE 2026 · [2015]
Why: The Scottish guidelines say this and ask that the advice is clearly documented. NICE likewise says to explain which symptoms to look out for and when to return, and that written information may be appropriate.
“It is also important for clinicians to provide a ‘safety net’ and ensure people know what symptoms to monitor and when to return if their condition does not improve or change.”
Scottish Government and the Centre for Sustainable Delivery 2025
Why: The count of three visits is Scottish: the guidelines there say vague symptoms in children may need a lower threshold for referral because of a higher risk of delayed diagnosis. NICE sets no number, and says to consider referral where a parent or carer has persistent concern.
“Referral to secondary care should be considered for children with repeat presentations (three or more times) of any symptoms which do not appear to be resolving or following an expected pattern, taking into account parent/carer and child concerns.”
Scottish Government and the Centre for Sustainable Delivery 2025
How care is usually carried out, read from the guidelines and standards cited. Your own team's protocol and their judgement come first; this page is for understanding it, not for doing it yourself.
None of the guidelines read grades its recommendations, and they agree on the outline: criteria set at a risk of 3% or more (Scottish Referral Guidelines 2025, which reviewed a lower threshold, kept 3% and describe it as in line with NICE) and safety netting for those not referred (both). NICE NG12 (updated April 2026) alone states that the person is told it is a cancer referral and that most people referred do not have cancer, and that the referral is made within 1 working day. The nations differ on what is timed. England times the diagnosis: a diagnosis or ruling out of cancer within 28 days of the urgent referral (NICE NG12; the Handbook to the NHS Constitution counts from receipt of the referral), and also has a 31-day wait from decision to treat and a 62-day wait from receipt of an urgent referral to first definitive treatment. The percentage of patients each must be met for and the detailed clock rules are in NHS England guidance that could not be read, so they are not stated here. Scotland times treatment: 62 days from urgent suspicion of cancer referral and 31 days from decision to treat, each for 95% of eligible patients. Wales times one pathway from the point of suspicion, which for a GP referral is the day it is sent: 62 days to first definitive treatment for at least 75%. In Scotland and Wales the receiving specialist may regrade a referral after triage, telling the referrer and the patient. Northern Ireland, by Cancer Research UK's account, has 62-day and 31-day treatment targets and no diagnosis standard. No source read compares the outcomes of these designs, so none is shown here as the better one.
NICE 2026 · Scottish Government and the Centre for Sustainable Delivery 2025 · Public Health Scotland 2026 · Welsh Government 2024 · Department of Health and Social Care 2025 · Cancer Research UK 2026
Where it differs: NICE NG12 defines the referral by its outcome, not by the date of the first appointment: "Person to receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their GP for suspected cancer." Its own vocabulary of urgency is separate: urgent means before 2 weeks and very urgent within 48 hours, used for tests and appointments in individual recommendations. The Handbook to the NHS Constitution for England puts the 28 days as a right, counted from receipt of the referral and covering urgent screening referrals and urgent referrals with breast symptoms too: "to the date you will be informed of a diagnosis or that cancer is ruled out". It also lists two pledges: "a maximum one month (31-day) wait from a decision to treat, or earliest clinically appropriate date, to treatment of cancer" and a maximum 62-day wait from receipt of an urgent referral, or a consultant upgrade, to first definitive treatment.
Evidence: A definition, not a graded recommendation. NICE's update information records: "October 2023: We updated the definition of suspected cancer pathway referral in line with NHS England's standard on faster diagnosis of cancer." Cancer Research UK: "From October 2023, this 2-week target was replaced by the Faster Diagnosis standard (see below)." The Handbook adds that the 31-day standards for first and subsequent treatments "have been combined into one measure from 1 October 2023". NICE points to NHS England for the detail; that guidance could not be read, so the percentage of patients each standard must be met for, and the detailed clock rules, are a gap on this page.
NICE 2026 · Department of Health and Social Care 2025 · Cancer Research UK 2026
Where it differs: The guidelines are written for any primary care setting and any member of the clinical team. The receiving specialty triages the referral and may regrade it to urgent or routine, or regrade a routine referral upwards: "It is essential that the patient is kept informed about any change in referral priority." The two national standards are timed to treatment, not to diagnosis: 62 days from urgent suspicion of cancer referral to first treatment, and 31 days from decision to treat to first treatment, each for 95% of eligible patients. The documents read set no standard for the day a person is told the diagnosis.
Evidence: Public Health Scotland, quarter ending 30 June 2026: "73.6% of patients started treatment within 62 days, compared with 72.2% in the previous quarter, and 83.7% in the quarter ending 31 December 2019." and "94.8% of patients started treatment within 31 days, compared with 94.5% in the previous quarter, and 96.5% in the quarter ending 31 December 2019." There were 4,492 eligible referrals under the 62-day standard in that quarter.
Scottish Government and the Centre for Sustainable Delivery 2025 · Public Health Scotland 2026
Where it differs: Wales measures a single pathway that starts at the point of suspicion, whoever first suspects cancer and wherever. For a referral from primary care the circular says: "For primary care referrals there will be little change except the clock will start at the date the GP sent the referral rather than receipt of referral by secondary care." The specialist may downgrade a referral on reviewing it, and the reasons go to the referrer and the patient. There is one target, to treatment, and none for the day of diagnosis, though decisions must be communicated "in a timely manner and within 24 hours for diagnosis".
Evidence: Welsh Health Circular WHC/2024/07 (version 6.5, April 2024): "The performance target for the SCP from December 2020 is that at least 75% of patients start their first definitive treatment within 62 days of the point of suspicion." Wales's current performance against it was not read for this page.
Where it differs: Cancer Research UK lists Northern Ireland with England and Scotland as having two targets to treatment, 62 days and 31 days, and with Scotland and Wales as having no target for the day of diagnosis: "Scotland, Northern Ireland and Wales do not have a Faster Diagnosis Standard target."
Evidence: A charity's patient page, last reviewed 9 October 2026, not Northern Ireland's own guidance. It gives no percentage for either target. The Department of Health's page on cancer waiting times refused a script on 17 November 2026, so Northern Ireland's referral guidance, the percentages, any separate standard and current performance are not given here.
Where it differs: For people with symptoms such as unexplained weight loss, tiredness, abdominal pain or nausea, or a GP's gut feeling, that fit no single cancer's criteria. NICE NG12 defines the pathway for England. In Scotland some health boards have a Rapid Cancer Diagnostic Service and others give GPs direct access to imaging: "The availability of these pathways varies across NHS Boards."
Evidence: NICE: "Non-specific symptoms pathways are designed for people whose symptoms do not clearly fit into a suspected cancer referral pathway as defined by this guideline." The Scottish guidelines describe GP gut feeling as predictive of cancer and usable alongside symptom criteria. No source read gives the proportion of people on these pathways who are found to have cancer.
Scottish Government and the Centre for Sustainable Delivery 2025 · NICE 2026
| Recommendation | Grade, as printed | Source |
|---|---|---|
| Tell people they are being referred to a cancer service and that most people referred will not have cancer | [2015] | NICE 2026 |
| Make the referral within 1 working day of the decision | [2005] | NICE 2026 |
| Urgent means before 2 weeks “To happen or be done before 2 weeks.” | Definition (not graded) | NICE 2026 |
| Very urgent means within 48 hours “To happen within 48 hours.” | Definition (not graded) | NICE 2026 |
| England: a suspected cancer pathway referral is defined by the 28-day outcome (definition updated October 2023) “Person to receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their GP for suspected cancer.” | Definition (not graded) | NICE 2026 |
| Safety netting has two parts: acting on results, and monitoring people at low but not no risk “The active monitoring in primary care of people who have presented with symptoms.” | Definition (not graded) | NICE 2026 |
| Consider a planned or patient-initiated review for people with a symptom linked to cancer who do not meet criteria | [2015] | NICE 2026 |
| England: a right to a maximum 28-day wait from receipt of an urgent referral to being told of a diagnosis or that cancer is ruled out “a maximum 28-day wait from receipt of an urgent referral for suspected cancer, receipt of urgent referral from a cancer screening programme, or receipt of urgent referral with breast symptoms (where cancer not suspected) to the date you will be informed of a diagnosis or that cancer is ruled out” | Right in the NHS Constitution handbook (not graded) | Department of Health and Social Care 2025 |
| England: 62 days from receipt of an urgent referral to first definitive treatment (no percentage stated in the handbook) “a maximum 2-month (62-day) wait from receipt of an urgent GP (or other referrer) referral for urgent suspected cancer or breast symptomatic referral, or urgent screening referral, or consultant upgrade, to first definitive treatment of cancer” | Government pledge (not graded) | Department of Health and Social Care 2025 |
| England: 31 days from decision to treat to treatment (no percentage stated in the handbook) “a maximum one month (31-day) wait from a decision to treat, or earliest clinically appropriate date, to treatment of cancer” | Government pledge (not graded) | Department of Health and Social Care 2025 |
| Local arrangements for a maximum wait for non-urgent referrals “Put in place local arrangements to ensure that there is a maximum waiting period for non-urgent referrals, in accordance with national targets and local arrangements.” | [2005] | NICE 2026 |
| Scotland kept the referral threshold at a positive predictive value of 3% or more “Considering this modest effect on cancer detection and the current pressures on diagnostic services, the Steering Group decided to keep the current Guideline’s PPV threshold at equal to or greater than 3%.” | Steering group decision (not graded) | Scottish Government and the Centre for Sustainable Delivery 2025 |
| Scotland: 62 days from urgent suspicion of cancer referral to first treatment, 95% “The 62-day standard states that 95% of eligible patients should wait no longer than 62 days from urgent suspicion of cancer referral to first cancer treatment.” | National standard (not graded) | Public Health Scotland 2026 |
| Scotland: 31 days from decision to treat to first treatment, 95% “The 31-day standard states that 95% of eligible patients should wait no longer than 31 days from decision to treat to first cancer treatment.” | National standard (not graded) | Public Health Scotland 2026 |
| Wales: 62 days from the point of suspicion to first definitive treatment, at least 75% “The performance target for the SCP from December 2020 is that at least 75% of patients start their first definitive treatment within 62 days of the point of suspicion.” | Performance target (not graded) | Welsh Government 2024 |
| Wales: decisions communicated to the patient and their primary care clinician within 24 hours for a diagnosis “Clinicians in secondary and tertiary care must ensure that all decisions relating to a patient’s care or treatment are communicated to the patient and their primary care clinician in a timely manner and within 24 hours for diagnosis.” | Requirement of the circular (not graded) | Welsh Government 2024 |